Cryoport, Inc. (CYRX)
Pharmaceutical Preparations · Healthcare · $738M
Intrinsic Value (Consensus)
$19.78
Current Price
$14.71
Margin of Safety
+34.5%
34.5% Below Intrinsic Value
Value: $20
Price: $15
Valuation Model Estimates
Current Price: $14.71
DCF (Discounted Cash Flow)
Not applicable
—
Graham Number
$17.76
Earnings Power Value
$13.59
Relative Value (P/E)
$28.00
Dividend Discount Model
Not applicable
—
Consensus Value
$19.78
Model Assumptions
Discount Rate
10.3%
Growth Rate
5.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
C
62
Profitability
22/25
Strength
14/25
Valuation
22/25
Growth
4/25
Financial Health Signals
Negative free cash flow — company is burning cash
Declining revenue — top line is shrinking
Low debt — conservative balance sheet
Key Financials
- EPS (TTM)
- $1.40
- EPS (Forward)
- $1.47
- Book Value
- $10.01
- P/E Ratio
- 20.0
- Forward P/E
- 19.0
- PEG Ratio
- —
- ROE
- 15.6%
- Debt/Equity
- 0%
- Revenue Growth
- -22.9%
- Earnings Growth
- 5.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance